LY88074 Trimethyl ether

Cat. No.: HY-135583: Fiche technique Instruction de manipulation
FAQs
Technical Support

LY88074 Trimethyl ether (Example 1) is useful for the inhibition of the various estrogen deficient conditions, which are associated with estrogen deprivation syndrome including osteoporosis and hyperlipidemia.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

LY88074 Trimethyl ether Chemical Structure

CAS No. : 63675-87-6

Size	Stock	Quantité
10 mg	Obtenir un devis 4 - 5 weeks 5 - 6 weeks 6 - 7 weeks 3 - 4 weeks	Estimated Time of Arrival: December 31
50 mg	Obtenir un devis 4 - 5 weeks 5 - 6 weeks 6 - 7 weeks 3 - 4 weeks	Estimated Time of Arrival: December 31
250 mg	Obtenir un devis 4 - 5 weeks 5 - 6 weeks 6 - 7 weeks 3 - 4 weeks	Estimated Time of Arrival: December 31
500 mg	Obtenir un devis
1 g	Obtenir un devis

Synthetic products have potential research and development risk.

or Bulk Inquiry

* Veuillez sélectionner la quantité avant d'ajouter des articles.

This product is a controlled substance and not for sale in your territory.

Recommandations en vedette

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Voir tous les produits spécifiques à Isoform Estrogen Receptor/ERR:

Voir toutes les isoformes

Estrogen receptor ERα ERβ ERRα ERRβ ERRγ

Activité biologique
Pureté et documentation
Références
Avis client

Description	LY88074 Trimethyl ether (Example 1) is useful for the inhibition of the various estrogen deficient conditions, which are associated with estrogen deprivation syndrome including osteoporosis and hyperlipidemia^[1].
Masse moléculaire	404.48
Formule	C₂₄H₂₀O₄S
CAS No.	63675-87-6
SMILES	O=C(C1=C(C2=CC=C(OC)C=C2)SC3=CC(OC)=CC=C31)C4=CC=C(OC)C=C4
Livraison	Room temperature in continental US; may vary elsewhere.
Stockage	Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation	Fiche technique (270 KB) Instruction de manipulation (2659 KB)
Références	[1]. George Joseph Cullinan, et al. 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome.WO1999025706A1.